RNS Number : 9564S
Cirata PLC
19 June 2024
 

19 June 2024

Cirata plc

("Cirata" or the "Company")

 

Total Voting Rights

 

Notification under Rule 5.6.1 Financial Conduct Authority Disclosure and Transparency Rules:

 

The Company's issued share capital at 31 May 2024 consisted of 115,827,302 ordinary shares of ten pence each with voting rights admitted to trading. The Company holds no ordinary shares in Treasury.

 

Therefore, the total number of voting rights in the Company is 115,827,302. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the DTRs.

 

Of the total of 115,827,302 Ordinary Shares of ten pence each:

-     115,827,302 are admitted under ISIN JE00B6Y3DV84, ticker CRTA.

 

For further information, please contact:

 

FTI Consulting

Rob Mindell / Kwaku Aning / Matt Dixon

+44 (0)20 3727 1137

Stifel (Nomad and Joint Broker)

Fred Walsh / Ben Good

+44 (0)20 7710 7600

Liberum (Joint Broker)

Max Jones / Ben Cryer / Miquela Bezuidenhoudt

+44 (0)20 3100 2000

 
About Cirata

Cirata accelerates data-driven revenue growth by automating data transfer and integration to modern cloud analytics and AI platforms without downtime or disruption. With Cirata, data leaders can leverage the power of AI and analytics across their entire enterprise data estate to freely choose analytics technologies, avoid vendor, platform, or cloud lock-in while making AI and analytics faster, cheaper, and more flexible. Cirata's portfolio of products and technology solutions make strategic adoption of modern data analytics efficient and automated. For more information about Cirata, visit www.cirata.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVREANKPFDKLEFA